Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The 2017 foundational studies confirmed that 5amino1mq reduces NAD consumption via NNMT inhibition, improves glucose clearance, and decreases fat accumulation.In subsequent years, the scope expanded: a 2021 study in obese mice validated its antiobesity effects, and 2024 research revealed improvements in muscle function in aged mice.To date, the compound remains in the preclinical research stage, with no largescale human clinical trials or FDA approval for human use
LOVE THIS PRODUCT
Quality control measures are implemented throughout the compounding process to verify the accuracy of ingredient measurements, sterility of the final product, and absence of particulate matter or other contaminants
Animal studies show BPC-157 accelerates tendon-to-bone healing, improves collagen organization, and reduces inflammatory markers in tendon tissue
